ebomi
Colour theme
Sign in
Insider · CIK 0001565020

Vivo Ventures VII, LLC

CIK 0001565020 Name as filed on the most recent filing

Filed as Vivo Ventures VII, LLC (17)

42 transaction lines · from 17 filings · filed 2013-05-20 to 2022-01-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

3 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-01-31 P, Open-market purchase Sierra Oncology, Inc.SRRA 21,600,000, acquired Open Form 4 filing 0001213900-22-004647
2018-08-30 P, Open-market purchase Airxpanders IncAXP 2 lines 3,367,763, acquired Open Form 4 filing 0001615774-18-009063
2017-09-14 S, Open-market sale Codexis IncCDXS 2 lines 6,121,500, disposed Open Form 4 filing 0001615774-17-005168
2017-03-02 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 3,900,000, disposed Open Form 4 filing 0001615774-17-000876
2017-03-01 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 3,098,000, disposed Open Form 4 filing 0001615774-17-000876
2017-02-28 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 6,100,000, disposed Open Form 4 filing 0001615774-17-000876
2016-11-18 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 10,224,000, disposed Open Form 4 filing 0001615774-16-008485
2016-11-16 S, Open-market sale Aclaris Therapeutics, Inc.ACRS 2 lines 10,684,049, disposed Open Form 4 filing 0001615774-16-008485
2016-09-08 S, Open-market sale Codexis IncCDXS 2 lines 474,624, disposed Open Form 4 filing 0001225208-16-039231
2016-08-16 S, Open-market sale Codexis IncCDXS 2 lines 155,220, disposed Open Form 4 filing 0001225208-16-038071
2016-08-15 S, Open-market sale Codexis IncCDXS 2 lines 213,700, disposed Open Form 4 filing 0001225208-16-038071
2016-08-04 S, Open-market sale Codexis IncCDXS 2 lines 208,420, disposed Open Form 4 filing 0001225208-16-037558
2016-08-03 S, Open-market sale Codexis IncCDXS 2 lines 128,949, disposed Open Form 4 filing 0001225208-16-037558
2015-11-09 S, Open-market sale MEI Pharma, Inc.MEIP 275,366, disposed Open Form 4 filing 0001225208-15-020609
2015-11-06 S, Open-market sale MEI Pharma, Inc.MEIP 13,986, disposed Open Form 4 filing 0001225208-15-020609
2015-11-05 S, Open-market sale MEI Pharma, Inc.MEIP 431,011, disposed Open Form 4 filing 0001225208-15-020609
2015-10-13 P, Open-market purchase Aclaris Therapeutics, Inc.ACRS 2 lines 4,999,995, acquired Open Form 4 filing 0001209191-15-075198
2015-10-07 P, Open-market purchase Aclaris Therapeutics, Inc.ACRS 2 lines 146,872, acquired Open Form 4 filing 0001209191-15-075023
2015-07-21 P, Open-market purchase ProNAi Therapeutics IncDNAI 2 lines 3,740,000, acquired Open Form 4 filing 0001209191-15-061940
2013-10-29 S, Open-market sale MEI Pharma, Inc.MEIP 6,252, disposed Open Form 4 filing 0000904454-13-001121
2013-10-28 S, Open-market sale MEI Pharma, Inc.MEIP 323,435, disposed Open Form 4 filing 0000904454-13-001121
2013-10-25 S, Open-market sale MEI Pharma, Inc.MEIP 2,131,180, disposed Open Form 4 filing 0000904454-13-001121
2013-10-02 S, Open-market sale MEI Pharma, Inc.MEIP 4,861,507, disposed Open Form 4 filing 0000904454-13-001090
2013-10-01 S, Open-market sale MEI Pharma, Inc.MEIP 1,050,671, disposed Open Form 4 filing 0000904454-13-001090
2013-06-28 S, Open-market sale MEI Pharma, Inc.MEIP 55,598, disposed Open Form 4 filing 0000904454-13-000776
2013-06-11 S, Open-market sale MEI Pharma, Inc.MEIP 1,842,929, disposed Open Form 4 filing 0000904454-13-000695
2013-05-16 S, Open-market sale MEI Pharma, Inc.MEIP 157,994, disposed Open Form 4 filing 0000904454-13-000586

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 3
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. VIVO VENTURES VII, LLC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001565020

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.